Research Synthesis: Melatonin Aging
Clarify in the abstract and key findings that the evidence is mixed and does not support broad causal or policy claims about melatonin's anti-aging effects. Explicitly state that the synthesis is mechanistic and hypothesis-generating rather than definitive.; Ensure that all claims in the 'Key Findings' and 'Conclusion' sections are explicitly bounded by the evidence tiers and directness ratings provided in the manuscript (e.g., B2, A1, B1; indirect, review, direct).; Add a brief statement in the abstract and conclusion about the lack of long-term safety data in older adults, as this is a critical limitation for any potential clinical translation.
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
To resubmit, address
- Clarify in the abstract and key findings that the evidence is mixed and does not support broad causal or policy claims about melatonin's anti-aging effects. Explicitly state that the synthesis is mechanistic and hypothesis-generating rather than definitive.
- Ensure that all claims in the 'Key Findings' and 'Conclusion' sections are explicitly bounded by the evidence tiers and directness ratings provided in the manuscript (e.g., B2, A1, B1; indirect, review, direct).
- Add a brief statement in the abstract and conclusion about the lack of long-term safety data in older adults, as this is a critical limitation for any potential clinical translation.
Minor issues
- The manuscript explicitly states that the evidence base is mixed and heterogeneous, which precludes a strong clinical or policy claim. This is appropriately reflected in the conclusion but should be emphasized earlier in the abstract and key findings to avoid misinterpretation by readers seeking definitive guidance.
Reviewer note
This is a high-quality rapid evidence synthesis with a transparent, auditable protocol and a well-integrated argument. The manuscript excels in explicit search scope, rigorous source admission, and clear limitations. The synthesis quality is strong, with coherent integration of heterogeneous evidence across outcome classes. The primary issue is mild overclaim in the framing of the abstract and key findings, where the manuscript could more explicitly state that the evidence is mixed and does not support broad causal or policy claims. The conclusion is appropriately cautious and bounded, but the abstract and key findings should reflect this caution more prominently to avoid misinterpretation. The source grounding is excellent, with citations directly supporting the claims. The limitations and gaps are material and well-articulated, particularly the lack of long-term safety data and the mechanistic-to-clinic gap. The manuscript is salvageable with bounded edits to clarify the bounded nature of the conclusions.
Panel metadata
Models: mimo-v2.5-pro + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: longevity
Author: Dominic Lynch
Author ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 2, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: c28738ef-0ca1-49af...